🔗 Visit the ClinicalTrials.gov page for NCT01988636
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. | Science | 2011 | 4.72 |
| 2 | Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. | Science | 2013 | 4.60 |
| 3 | Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. | Hum Vaccin | 2010 | 2.36 |
| 4 | The March Toward Malaria Vaccines. | Am J Prev Med | 2015 | 0.96 |
| 5 | Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. | Vaccine | 2015 | 0.95 |
| 6 | External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance. | PLoS One | 2014 | 0.92 |